Bringing the Human Factor to the Last Mile of AI-Assisted Clinical Decisions ajmc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajmc.com Daily Mail and Mail on Sunday newspapers.
Drugmakers now have wonkier than usual technical draft recommendations from the Centers for Medicare and Medicaid Services on the agency’s process to calculate and pay mandatory rebates if the companies raise the price of certain drugs more rapidly than the annual inflation rate.
Scandion Oncology engages former ASCO executive as clinical advisor
Scandion Oncology is pleased to announce that we have appointed Dr. Richard L. Schilsky, a seasoned and highly profiled international leader as a member of our clinical advisory board (CAB). Dr. Schilsky is the former CMO and Executive Vice President of the American Society of Clinical Oncology (ASCO) and a long-time faculty member of the University of Chicago.
Scandion Oncology A/S
Publicerad: 21 april 2021, 11:30
Copenhagen, April 21, 2021. Scandion Oncology, The Cancer Drug Resistance Company, is pleased to announce that
Richard L. Schilsky, MD, FACP, FSCT, FASCO has accepted to join the clinical advisory board of Scandion Oncology.
email article When I started digging, I was horrified. Law student Aurora Kim Paradisis, RN, EdD, discussing what appears to be a trend of unjust nursing board discipline. I m not sure that you have the necessary experience or skills to do this job at this moment. Sen. Richard Burr (R-N.C.) addressing Xavier Becerra during the first of two Senate hearings on his nomination for HHS Secretary. When we go to campus we are the only ones there. Angeline Dukes, a University of California Irvine neuroscience graduate student, who helped create the Black in Neuro online community of scholars.
email article
After close to a decade at the helm, Richard Schilsky, MD, has retired from his role as chief medical officer of the American Society of Clinical Oncology (ASCO).
His legacy as the organization s first CMO will be what he calls the ASCO research enterprise launching ASCO s first-ever clinical trial, increasing its ability to conduct observational studies, and tapping into the 40,000-person membership for original survey-based research. It was clear that while ASCO was a tremendous vehicle to disseminate and amplify research findings that were generated by various entities, ASCO itself didn t actually do any research to contribute any knowledge to the field, Schilsky told